Publication Name	World Journal of Virology
Manuscript ID	16392
Country	Spain

Received	2015-01-15 08:48
Peer-Review Started	2015-01-16 15:10
To Make the First Decision	2015-04-27 15:38
Return for Revision	2015-04-28 13:57
Revised	2015-05-07 15:02
Second Decision	2015-06-01 08:45
Accepted by Journal Editor-in-Chief	2015-06-02 14:17
Accepted by Executive Editor-in-Chief	2015-06-11 15:50
Articles in Press	2015-06-11 15:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-09 14:14
Publish the Manuscript Online	2015-08-13 10:30

ISSN	2220-3249 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Editorial
Article Title	Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics
Manuscript Source	Invited Manuscript
All Author List	Victor Asensi, Julio Collazos and Eulalia Valle-Garay
Funding Agency and Grant Number
Corresponding Author	Victor Asensi, MD, PhD, Infectious Diseases-HIV Unit, Hospital Universitario Central de Asturias, Oviedo University School of Medicine, Avenida de Roma s/n, 33013 Oviedo, Spain. vasensia@gmail.com
Key Words	Pharmacogenomics; Pharmacokinetics; Antiretroviral drugs; Adverse effects; Human immunod¬e¬ficiency virus infection; Single nucleotide polymorphisms
Core Tip	Pharmacogenetics may play an important role in the near future for the treatment of human immunodeficiency virus-infection, as exemplified by the HLAB*5701 genotyping to prevent the abacavir-associated hypersensitivity reaction. Diverse other single nucleotide polymorphisms have been described as related to certain pharmacokinetic characteristics and adverse effects of antiretroviral drugs. In this Editorial we summarize the current knowledge on this rapidly evolving field.
Publish Date	2015-08-13 10:30
Citation	Asensi V, Collazos J, Valle-Garay E. Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World J Virol 2015; 4(3): 169-177
URL	http://www.wjgnet.com/2220-3249/full/v4/i3/169.htm
DOI	http://dx.doi.org/10.5501/wjv.v4.i3.169

Full Article (PDF)	WJV-4-169.pdf
Full Article (Word)	WJV-4-169.doc
Manuscript File	16392-Review.docx
Answering Reviewers	16392-Answering reviewers.pdf
Audio Core Tip	16392-Audio core tip.wav
Conflict-of-Interest Disclosure Form	16392-Conflict-of-interest statement.pdf
Copyright License Agreement	16392-Copyright assignment.PDF
Peer-review Report	16392-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	16392-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16392-Scientific misconduct check.pdf
Scientific Editor Work List	16392-Scientific editor work list.pdf